Kisho

Microbion Corporation — Rare Disease Pipeline | Kisho | Kisho

Microbion Corporation

Other

Orphan Designations

FDA Approvals

Rare Diseases

News Articles

Disease	Drug(s)	Designation	Approved
post 5-alpha-reductase inhibitors treatment syndrome	Bismuth-1,2-ethanedithiol; 1,2-Bis-((1,3-dithia-2-bismolan)-2-yl) thioethane	Orphan Designation	-
post-treatment Lyme disease syndrome	Bismuth-1,2-ethanedithiol; 1,2-Bis-((1,3-dithia-2-bismolan)-2-yl) thioethane	Orphan Designation	-
pulmonary non-tuberculous mycobacterial infection	pravibismane	Orphan Designation	-
treatment-refractory schizophrenia	Bismuth-1,2-ethanedithiol; 1,2-Bis-((1,3-dithia-2-bismolan)-2-yl) thioethane	Orphan Designation	-